Eli Lilly & Co.’s stock has reached new highs in recent days, becoming the first pharmaceutical company to hit a $1 trillion valuation. The surge has also lifted the founding family’s private ...

A fresh call from Bernstein has Wall Street doing a double-take. Bernstein just reset Eli Lilly’s price target. Analyst Breen cites talks about GLP-1 catalysts, robust U.S. policy, and promising ...

is the Neighborhood News reporter for San Patricio County alongside Victoria Balderama. SAN PATRICIO COUNTY, Tx — Corpus Christi Water (CCW) hosted a public information session to discuss the ...

An ambulance driving the wrong way nearly caused a collision with jockeys and horses Saturday during the eighth race at Evangeline Downs in Opelousas. A video circulating on social media shows eight ...

Marvel Cinematic Universe Rumor About Doctor Strange's Avengers: Doomsday Role Offers Connection To Multiverse Of Madness (And I Hope It's Legit) Marvel Cinematic Universe Wait, Is Paul Bettany ...

Eli Lilly’s stock (NYSE: LLY) soared nearly 50%, in the past six months, driven not only by outstanding earnings and a notable margin increase, but also by reaching a $1T market cap and excitement ...

Filed Under: Ant-Man 2: Ant-Man And The Wasp Pretty much every past MCU cast member has been, at some point, rumored to appear in the upcoming blockbusters, so it's not unreasonable to assume that ...

Pharmaceutical company Eli Lilly is looking to roll out a daily weight loss pill for patients with obesity and type 2 diabetes. A recent trial showed the drug enabled people with both conditions to ...

Forbes contributors publish independent expert analyses and insights. Peter Cohan, a Boston-based senior contributor, covers stocks. Eli Lilly achieved a $1 trillion market cap, a healthcare first, ...

Eli Lilly delivered 54% revenue growth in Q3 2025, raised full-year guidance, and remains a defensive haven amid market volatility. LLY's obesity and diabetes franchise, led by Zepbound, Mounjaro, and ...